Evidence map›Paper›PMID 33760077›Full record

Trial reportThe British journal of surgery2021

Bridging the age gap in breast cancer: cluster randomized trial of two decision support interventions for older women with operable breast cancer on quality of life, survival, decision quality, and treatment choices.

L Wyld, M W R Reed, K Collins, M Burton, K Lifford, A Edwards, S Ward, G Holmes, J Morgan, M Bradburn and 31 more

Open access · bronzeAbstract readMulticenter StudyPragmatic Clinical TrialRandomized Controlled Trial
In one paragraph

Trial report in The British journal of surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 6 pooled it
12.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 6 syntheses or guidelines pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Decision aids for people facing health treatment or screening decisions.The Cochrane database of systematic reviews · 2024
    Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Review
  12. Surgery in Older Cancer Patients.Current oncology reports · 2026
    Review
  13. Survivorship Issues in Older Adults with Breast Cancer.Current breast cancer reports · 2025
    Article
  14. Article
  15. Review
  16. Article
  17. Research and practice priorities in pilonidal sinus disease: a consensus from the PITSTOP study.Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland · 2024
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

41 authors at 15 institutions in 3 countries.

L WyldDepartment of Oncology and Metabolism, University of Sheffield Medical School, Sheffield, UK.
M W R ReedBrighton and Sussex Medical School, Falmer, Brighton, UK.ORCID 0000-0001-7442-2132
K CollinsCollege of Health, Wellbeing and Life Sciences, Department of Allied Health Professions, Sheffield Hallam University, Sheffield, UK.
M BurtonCollege of Health, Wellbeing and Life Sciences, Department of Allied Health Professions, Sheffield Hallam University, Sheffield, UK.
K LiffordDivision of Population Medicine, Cardiff University, Cardiff, UK.
A EdwardsDivision of Population Medicine, Cardiff University, Cardiff, UK.
S WardDepartment of Health Economics and Decision Science, School for Health and Related Research, ScHARR, University of Sheffield, Sheffield, UK.ORCID 0000-0002-3344-0913
G HolmesDepartment of Health Economics and Decision Science, School for Health and Related Research, ScHARR, University of Sheffield, Sheffield, UK.ORCID 0000-0002-8861-9638
J MorganDepartment of Oncology and Metabolism, University of Sheffield Medical School, Sheffield, UK.ORCID 0000-0002-5337-5581
M BradburnClinical Trials Research Unit, School for Health and Related Research, University of Sheffield, Sheffield, UK.
S J WaltersClinical Trials Research Unit, School for Health and Related Research, University of Sheffield, Sheffield, UK.
A RingRoyal Marsden Hospital NHS Foundation Trust, London, UK.
T G RobinsonDepartment of Cardiovascular Sciences and NIHR Biomedical Research Centre, University of Leicester, Cardiovascular Research Centre, Glenfield General Hospital, Leicester, UK.
C MartinDepartment of Oncology and Metabolism, University of Sheffield Medical School, Sheffield, UK.
T ChaterClinical Trials Research Unit, School for Health and Related Research, University of Sheffield, Sheffield, UK.
K PembertonClinical Trials Research Unit, School for Health and Related Research, University of Sheffield, Sheffield, UK.
A ShresthaDepartment of Oncology and Metabolism, University of Sheffield Medical School, Sheffield, UK.
A NettleshipEpiGenesys, University of Sheffield, Sheffield, UK.
C MurrayEpiGenesys, University of Sheffield, Sheffield, UK.ORCID 0000-0001-6939-4384
M BrownEpiGenesys, University of Sheffield, Sheffield, UK.
P RichardsDepartment of Health Economics and Decision Science, School for Health and Related Research, ScHARR, University of Sheffield, Sheffield, UK.
K L CheungUniversity of Nottingham, Royal Derby Hospital, Derby, UK.
A ToddDepartment of Oncology and Metabolism, University of Sheffield Medical School, Sheffield, UK.
H HarderBrighton and Sussex Medical School, Falmer, Brighton, UK.
K BrainDivision of Population Medicine, Cardiff University, Cardiff, UK.
R A AudisioUniversity of Gothenberg, Sahlgrenska Universitetssjukhuset, Gothenberg, Sweden.ORCID 0000-0002-7538-4809
J WrightBrighton and Sussex Medical School, Falmer, Brighton, UK.
R SimcockBrighton and Sussex Medical School, Falmer, Brighton, UK.
F ArmitageWeston Park Hospital, Sheffield, UK.
M BursnallClinical Trials Research Unit, School for Health and Related Research, University of Sheffield, Sheffield, UK.
T GreenYorkshire and Humber Consumer Research Panel (yhcrp.org.uk), Leeds, UK.
D RevellYorkshire and Humber Consumer Research Panel (yhcrp.org.uk), Leeds, UK.
J GathYorkshire and Humber Consumer Research Panel (yhcrp.org.uk), Leeds, UK.
K HorganDepartment of Breast Surgery, Bexley Cancer Centre, St James's University Hospital, Leeds, UK.
C HolcombeLiverpool University Hospitals Foundation Trust, Liverpool, UK.
M WinterWeston Park Hospital, Sheffield, UK.
J NaikPinderfields Hospital, Mid Yorkshire NHS Foundation Trust, Wakefield, UK.
R ParmeshwarUniversity Hospitals of Morecambe Bay, Lancaster, UK.
M GosneyRoyal Berkshire NHS Foundation Trust, Reading, UK.
M HattonWeston Park Hospital, Sheffield, UK.
A M ThompsonDepartment of Surgery, Baylor College of Medicine, Houston, Texas, USA.
University of Sheffield · GBBrighton and Sussex Medical School · GBCardiff University · GBWeston Park Cancer Centre · GBSheffield Hallam University · GBBaylor College of Medicine · USMid Yorkshire Hospitals NHS Trust · GBRoyal Berkshire NHS Foundation Trust · GBRoyal Marsden NHS Foundation Trust · GBSahlgrenska University Hospital · SESt James's University Hospital · GBUniversity Hospitals of Morecambe Bay NHS Foundation Trust · GBUniversity of Leicester · GBUniversity of Liverpool · GBUniversity of Nottingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRates of surgery and adjuvant therapy for breast cancer vary widely between breast units. This may contribute to differences in survival. This cluster RCT evaluated the impact of decision support interventions (DESIs) for older women with breast cancer, to ascertain whether DESIs influenced quality of life, survival, decision quality, and treatment choice.

methodsA multicentre cluster RCT compared the use of two DESIs against usual care in treatment decision-making in older women (aged at least ≥70 years) with breast cancer. Each DESI comprised an online algorithm, booklet, and brief decision aid to inform choices between surgery plus adjuvant endocrine therapy versus primary endocrine therapy, and adjuvant chemotherapy versus no chemotherapy. The primary outcome was quality of life. Secondary outcomes included decision quality measures, survival, and treatment choice.

resultsA total of 46 breast units were randomized (21 intervention, 25 usual care), recruiting 1339 women (670 intervention, 669 usual care). There was no significant difference in global quality of life at 6 months after the baseline assessment on intention-to-treat analysis (difference -0.20, 95 per cent confidence interval (C.I.) -2.69 to 2.29; P = 0.900). In women offered a choice of primary endocrine therapy versus surgery plus endocrine therapy, knowledge about treatments was greater in the intervention arm (94 versus 74 per cent; P = 0.003). Treatment choice was altered, with a primary endocrine therapy rate among women with oestrogen receptor-positive disease of 21.0 per cent in the intervention versus 15.4 per cent in usual-care sites (difference 5.5 (95 per cent C.I. 1.1 to 10.0) per cent; P = 0.029). The chemotherapy rate was 10.3 per cent at intervention versus 14.8 per cent at usual-care sites (difference -4.5 (C.I. -8.0 to 0) per cent; P = 0.013). Survival was similar in both arms.

conclusionThe use of DESIs in older women increases knowledge of breast cancer treatment options, facilitates shared decision-making, and alters treatment selection. Trial registration numbers: EudraCT 2015-004220-61 (https://eudract.ema.europa.eu/), ISRCTN46099296 (http://www.controlled-trials.com).

Indexed as

Decision MakingDecision Support TechniquesAgedAged, 80 and overAntineoplastic Agents, HormonalBreast NeoplasmsChemotherapy, AdjuvantFemaleHealth Knowledge, Attitudes, PracticeHumansQuality of LifeAntineoplastic Agents, Hormonal

Identifiers

PMID33760077
PMCPMC10364907
OpenAlexW3137030093

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.